Target intelligence / Profile preview

Carnosine N-methyltransferase 1 (CARNMT1)

Target
CARNMT1
Molecular classification
Enzyme, Methyltransferase
01

Overview

Carnosine N-methyltransferase 1 (CARNMT1) is an enzyme responsible for the N1-position-specific methylation of the histidine residue in the dipeptide carnosine, transforming it into anserine, which is highly abundant in vertebrate skeletal muscle[1][3][4]. CARNMT1 also catalyzes histidine methylation in other peptides and a wide range of proteins, particularly those containing C3H zinc finger (ZF) motifs, with broad effects on protein function and RNA metabolism[1]. Its activity is essential for embryogenesis, as loss of function leads to embryonic lethality in model organisms. CARNMT1 is thus a methyltransferase with critical roles in post-translational protein modification and regulation of RNA-binding protein functions[1][3].

Other names
CARNMT1CARMEC9orf41HNMT-like protein
02

Mechanism of action

Histidine N1-methylation of carnosine and other histidine-containing peptides; Generation of anserine from carnosine; Methylation of RNA-binding proteins affecting RNA metabolism[1][3]

03

Biological functions

Protein histidine N-methylationRegulation of RNA metabolism (including pre-mRNA alternative splicing and mRNA degradation)Conversion of carnosine to anserineMethylation of peptides containing histidine residues
04

Disease associations

Essential for embryogenesis (embryonic lethality observed with deficiency)Other (no clear major disease association established, but see essential roles above)[1]
05

Safety considerations

Essential for embryonic development; loss-of-function leads to embryonic lethality in mice[1].No clinical safety concerns established for inhibitors or modulators as none are in widespread therapeutic use.
06

Biomarkers

Anserine levels (as a product of CARNMT1 activity)[1]1-methylhistidine (1MH) levels in proteins[1]

Beyond the preview

Go deeper on Carnosine N-methyltransferase 1 (CARNMT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carnosine N-methyltransferase 1 (CARNMT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call